Analysis of the evidence about the efficacy and safety of the CYD-TDV dengue vaccine and its potential licensing and implementation within the Mexican Universal Vaccination Program
Dengue is a major global public health problem which affects Latin America and Mexico. The prevention and control measures focusing on epidemiological surveillance and vector control have been partially effective as well as costly; thus, the development of a vaccine against dengue has created great...
Na minha lista:
Principais autores: | Mauricio Hernández-Ávila (Autor), José Ignacio Santos-Preciado (Autor) |
---|---|
Formato: | Livro |
Publicado em: |
Instituto Nacional de Salud Pública,
2016-02-01T00:00:00Z.
|
Assuntos: | |
Acesso em linha: | Connect to this object online. |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registros relacionados
-
Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico´s Universal Vaccination Program
por: Mauricio Hernández-Ávila, et al.
Publicado em: (2016) -
The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
por: Raksheeth Agarwal, et al.
Publicado em: (2017) -
Effectiveness of mass dengue vaccination with CYD-TDV (Dengvaxia®) in the state of Paraná, Brazil: integrating case-cohort and case-control designsResearch in context
por: Fredi Alexander Diaz-Quijano, et al.
Publicado em: (2024) -
Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
por: Ngoc Huu Tran, et al.
Publicado em: (2019) -
Vaccines licensed and in clinical trials for the prevention of dengue
por: J. Torresi, et al.
Publicado em: (2017)